Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis
- PMID: 26464311
- PMCID: PMC5111598
- DOI: 10.1002/hec.3259
Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis
Abstract
The health of carers and others close to the patient will often be relevant to economic evaluation, but it is very rarely considered in practice. This may reflect a lack of understanding of how the spillover effect of illness can be appropriately quantified. In this study we used three different approaches to quantify health spillovers resulting from meningitis. We conducted a survey of 1218 family networks affected by meningitis and used regression modelling to estimate spillover effects. The findings show that meningitis had long-term effects on family members' health, particularly affecting the likelihood of family members reporting anxiety and depression. These effects extended beyond a single close family member. These findings suggest that vaccinating against meningitis will bring significant health benefits not just to those that might have contracted the illness but also to their family networks. In methodological terms, different approaches for quantifying health spillovers provided broadly consistent results. The choice of method will be influenced by the ease of collecting primary data from family members in intervention contexts. © 2015 The Authors. Health Economics published by John Wiley & Sons Ltd.
Keywords: EQ-5D; economic evaluation; health valuation; informal care; spillovers.
© 2015 The Authors. Health Economics published by John Wiley & Sons Ltd.
Figures
References
- 
    - Al‐Janabi H, Flynn T, Coast J. 2011. QALYs and carers. PharmacoEconomics 29: 1015–1023. - PubMed
 
- 
    - Argimon J, Limon E, Vila J & Cabezas C. 2004. Health related quality of life in carers of patients with dementia. Family Practice 21: 454–457. - PubMed
 
- 
    - Basu A, Dale W, Elstein A & Meltzer D. 2010. A time tradeoff method for eliciting partner's quality of life due to patient's health states in prostate cancer. Medical Decision Making 30: 355–365. - PubMed
 
- 
    - Basu A & Meltzer D. 2005. Implications of spillover effects within the family for medical cost‐effectiveness analysis. Journal of Health Economics 24: 751–773. - PubMed
 
- 
    - Bilcke J, Van Damme P, Beutels P. 2009. Cost‐effectiveness of rotavirus vaccination: exploring caregiver(s) and “no medical care” disease impact in Belgium. Medical Decision Making 29: 33–50. - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
         
               
              